欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2025, Vol. 30 ›› Issue (7): 889-898.doi: 10.12092/j.issn.1009-2501.2025.07.003

• 基础研究 • 上一篇    下一篇

蛇床子素通过上调Tif1γ抑制TGF-β1/ Smad通路保护APAP诱导的小鼠肝损伤

何怡然1,何阳1,邓国艳1,樊志强1,汤紫照1,魏凤1,欧阳林旗1,2   

  1. 1湖南中医药大学第一附属医院,长沙  410007,湖南;2湖南中医药大学药学院,长沙  410208,湖南
  • 收稿日期:2024-07-02 修回日期:2024-08-06 出版日期:2025-07-26 发布日期:2025-07-02
  • 通讯作者: 欧阳林旗,博士,副主任药师,研究方向:临床中药学、中药药理学研究。 E-mail: oylqzyfy03@hnucm.edu.cn
  • 作者简介:何怡然,硕士,主管药师,研究方向:中药药理学研究。 E-mail: heyiranheyiran@163.com
  • 基金资助:
    湖南省自然科学基金(2024JJ9416);湖南省中医药科研计划项目(A2024026、B2023050);湖南省卫生健康委科研计划课题(C202313057956);湖南中医药大学校级科研基金(2022XYLH004、2021XJJJ040);国家中医优势专科建设项目(国中医药医政函(2024)90号);湖南省“十四五”中医重点专科-中药学(湘中医药函[2023]4号)

Osthole protects APAP-induced liver injury in mice by inhibiting the TGF-β1/Smad pathway through upregulation of Tif1γ

HE Yiran1, HE Yang1, DENG Guoyan1, FAN Zhiqiang1, TANG Zizhao1, WEI Feng1, OUYANG Linqi1,2   

  1. 1The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, Hunan, China; 2School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, Hunan, China
  • Received:2024-07-02 Revised:2024-08-06 Online:2025-07-26 Published:2025-07-02

摘要:

目的:探讨蛇床子素(osthole,Ost)保护对乙酰氨基酚(APAP)诱导的小鼠肝损伤的作用及分子机制。方法:建立APAP诱导小鼠肝损伤模型,并用Ost进行干预;生化法检测小鼠血浆中谷草转氨酶(AST)、谷丙转氨酶(ALT)、超氧化物歧化酶(SOD)、活性氧(ROS)、丙二醛(MDA)、乳酸脱氢酶(LDH)、谷胱甘肽过氧化物酶(GSH-PX)表达;苏木素-伊红(HE)染色观察小鼠肝脏组织结构变化;免疫荧光法检测小鼠肝脏组织转录中间因子1γ(Tif1γ)及Smad4表达;实时荧光定量PCR(qRT-PCR)检测小鼠肝脏组织IL-1β、IL-6、TNF-α及Smad4、Tif1γ mRNA表达;Western blot检测小鼠肝脏组织中Smad2/3、pSmad2/3蛋白的表达。结果:与对照组相比,模型组小鼠肝脏结构破坏、肝细胞死亡增多;ALT、AST、ROS、MDA及LDH升高,SOD及GSH-PX降低;IL-1β、IL-6及TNF-α mRNA表达升高。与模型组相比,Ost干预组小鼠肝脏结构改善、肝细胞死亡减少;ALT、AST、ROS、MDA及LDH降低,SOD及GSH-PX升高;IL-1β、IL-6及TNF-α mRNA表达降低。与对照组相比,模型组小鼠肝脏组织pSmad2/3、Smad4蛋白及Smad4 mRNA表达增加,Tif1γ蛋白及mRNA表达减少。与模型组相比,Ost干预组小鼠肝脏组织pSmad2/3、Smad4蛋白及Smad4 mRNA表达减少,Tif1γ蛋白及mRNA表达增加。结论:Ost可改善肝功能、减少氧化应激和炎症反应,保护APAP诱导的小鼠肝细胞损伤,机制与上调Tif1γ,削弱TGF-β1/Smad信号有关。

关键词: 蛇床子素, 转录中间因子1γ, TGF-β1/Smad信号通路, 肝损伤, 肝星状细胞

Abstract:

AIM: To investigate the protective effect of osthole (Ost) on APAP-induced liver injury in mice and its molecular mechanism. METHODS: We established the APAP-induced liver injury model in mice, and Ost was used to intervene. The expression of AST, ALT, SOD, ROS, MDA, LDH, GSH-PX in mice plasma were detected by biochemical method. HE staining was used to observe the changes of liver tissue structure. Immunofluorescence assay was used to detect the expression of Tif1γ and Smad4 in liver tissue. The mRNA expression of IL-1β, IL-6, TNF-α, Smad4, and Tif1γ were detected by qRT-PCR. Western blot was applied to assess the protein expression of Smad2/3 and pSmad2/3 in liver tissue. RESULTS: Compared with the control group, the liver structure destruction and hepatocyte death was increased, ALT, AST, ROS, MDA and LDH were increased, while SOD and GSH-PX were decreased, and the mRNA expressions of IL-1β, IL-6 and TNF-α were increased in the model group. Compared with the model group, the Ost intervention group had improved liver structure and decreased liver cell death; decreased ALT, AST, ROS, MDA and LDH, increased SOD and GSH-PX, and decreased expression of IL-1β, IL-6 and TNF-α mRNA. Compared with the control group, liver tissues of model mice showed increased expression of pSmad2/3, Smad4 protein and Smad4 mRNA, and decreased Tif1γ protein and mRNA. Compared with the model group, the liver tissues of the Ost intervention group showed decreased expression of pSmad2/3, Smad4 protein and Smad4 mRNA, and increased expression of Tif1γ protein and mRNA. CONCLUSION: Ost can improve liver function, reduce oxidative stress and inflammatory reaction, and protect hepatocyte damage induced by APAP in mice, which may be related to the up-regulation of Tif1γ and inhibition of TGF-β1/Smad signaling pathway.

Key words: osthole, Tif1γ, TGF-β1/Smad, liver injury, hepatic stellate cell

中图分类号: